GSK pulls out of $20 billion race for Pfizer consumer assets

LONDON (Reuters) - GlaxoSmithKline has quit the race to buy Pfizer's consumer healthcare business, endangering an auction the U.S. drugmaker hoped would bring in as much as $20 billion.

from Reuters: Business News http://ift.tt/2uaHeOR